Results 21 to 30 of about 33,069 (263)

Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)

Mycoses (Berlin), 2022
The Americas are home to biologically and clinically diverse endemic fungi, including Blastomyces, Coccidioides, Emergomyces, Histoplasma, Paracoccidioides and Sporothrix.
D. Cáceres, Laura C Echeverri Tirado, A. Bonifaz, A. Adenis, B. Gómez, Claudia Lizette Banda Flores, C. Canteros, Daniel Wagner Santos, Eduardo Arathoon, Elia Ramirez Soto, F. Queiroz-Telles, Ilan S. Schwartz, J. Zurita, L. Damasceno, N. Garcia, Norma B Fernández, O. Chincha, Patricia Araujo, R. Rabagliati, T. Chiller, G. Giusiano   +20 more
semanticscholar   +1 more source

Endemic Mycoses: Underdiagnosed and Underreported

Annals of Internal Medicine, 2022
lastomycosis, coccidioidomycosis, and histoplasmosis are the endemic mycoses that are most prevalent ...
G. Thompson, T. Chiller
semanticscholar   +1 more source

Endemic and Other Dimorphic Mycoses in The Americas

Journal of Fungi, 2021
Endemic fungi are thermally dimorphic fungi that have a limited geographic range and can cause both primary disease and opportunistic infections. The Americas are home to more genera of endemic fungi than anywhere else on earth.
S. Lockhart, Mitsuru Toda, Kaitlin Benedict, D. Cáceres, A. Litvintseva   +4 more
semanticscholar   +1 more source

An overview of antimicrobial resistance surveillance among healthcare-associated pathogens in South Africa

African Journal of Laboratory Medicine, 2018
Healthcare-associated infections are a serious public health concern resulting in morbidity and mortality particularly in developing countries. The lack of information from Africa, the increasing rates of antimicrobial resistance and the emergence of new
Ashika Singh-Moodley, Husna Ismail, Olga Perovic   +2 more
doaj   +1 more source

Prevalence of fungal infections using National Health Insurance data from 2009-2013, South Korea [PDF]

Epidemiology and Health, 2014
OBJECTIVES The symptoms of fungal infections vary from minor to severe. According to recent reports, fungal infection prevalence is increasing due to increases in the aging population and in patients with compromised immune systems.
Hee Jung Yoon, Hwa Young Choi, Young Kwon Kim, Yeong Jun Song, Moran Ki   +4 more
doaj   +1 more source

No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004–2017, Paris, France)

Frontiers in Medicine, 2021
Replacement of fluconazole by echinocandins as the first-line therapy for yeast-related fungemia could have an impact on both the mortality rate and the epidemiology of yeast species responsible for candidemia.
Stéphane Bretagne, Stéphane Bretagne, Stéphane Bretagne, Marie Desnos-Ollivier, Karine Sitbon, Olivier Lortholary, Olivier Lortholary, Olivier Lortholary, Didier Che, Françoise Dromer, Participants of the YEASTS   +10 more
doaj   +1 more source

Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation

mBio, 2015
Cryptococcus neoformans is a human opportunistic fungal pathogen causing severe disseminated meningoencephalitis, mostly in patients with cellular immune defects. This species is divided into three serotypes: A, D, and the AD hybrid.
Marie Desnos-Ollivier, Sweta Patel, Dorothée Raoux-Barbot, Joseph Heitman, Françoise Dromer   +4 more
doaj   +1 more source

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

Clinical Infectious Diseases, 2019
Background Invasive fungal diseases (IFDs) remain important causes of morbidity and mortality. The consensus definitions of the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group have ...
J. Donnelly, S. Chen, C. Kauffman, W. Steinbach, J. Baddley, P. Verweij, C. Clancy, J. Wingard, S. Lockhart, A. Groll, T. Sorrell, M. Bassetti, H. Akan, B. Alexander, D. Andes, É. Azoulay, R. Bialek, R. Bradsher, S. Bretagne, T. Calandra, A. Caliendo, E. Castagnola, M. Cruciani, M. Cuenca‐Estrella, C. Decker, S. Desai, B. Fisher, T. Harrison, C. Heussel, H. E. Jensen, C. Kibbler, D. Kontoyiannis, B. Kullberg, K. Lagrou, F. Lamoth, T. Lehrnbecher, Jurgen Loeffler, O. Lortholary, J. Maertens, O. Marchetti, K. Marr, H. Masur, J. Meis, C. Morrisey, M. Nucci, L. Ostrosky-Zeichner, L. Pagano, T. Patterson, J. Perfect, Z. Ráčil, E. Roilides, M. Ruhnke, Cornelia Schaefer Prokop, S. Shoham, M. Slavin, D. Stevens, G. Thompson, J. Vázquez, C. Viscoli, T. Walsh, A. Warris, L. Wheat, P. L. White, T. Zaoutis, P. Pappas   +64 more
semanticscholar   +1 more source

Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.

Journal of Infectious Diseases, 2020
In recent years, the global public health community has increasingly recognized the importance of antimicrobial stewardship (AMS) in the fight to improve outcomes, decrease costs, and curb increases in antimicrobial resistance around the world.
Melissa D. Johnson, R. Lewis, E. D. Dodds Ashley, L. Ostrosky-Zeichner, T. Zaoutis, G. Thompson, D. Andes, T. Walsh, P. Pappas, O. Cornely, J. Perfect, D. Kontoyiannis   +11 more
semanticscholar   +1 more source

Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp. [PDF]

Mycoses
ABSTRACT Background Malassezia genus includes lipodependent commensal yeasts of humans and animals' skin and mucous membranes. It can cause dermatological pathologies, and azoles are mainly used for treatment. However, in vitro susceptibility testing has shown decreased sensitivity to these antifungals.
Galvis-Marín JC, Celis-Ramírez AM, Tabares-Villa FA, Zuluaga-Vélez A, Sepúlveda-Arias JC.   +4 more
europepmc   +2 more sources